Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1510.85 -5.30 (-0.35%) | NSE 1509.90 -7.10 (-0.47%) | Trade | Add

BSE Live

Jan 16, 16:01

1510.85 -5.30 (-0.35%)

Volume

AVERAGE VOLUME

5-Day

28,838

10-Day

23,496

30-Day

14,779

495,166

Prev. Close

1516.15
Open Price

1516.15

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 16, 15:55

1509.90 -7.10 (-0.47%)

Volume

AVERAGE VOLUME

5-Day

429,775

10-Day

351,579

30-Day

253,304

107,415

Prev. Close

1517.00
Open Price

1512.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ipca Laboratories (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.24	25.24	25.24	25.17	25.14
Total Share Capital	25.24	25.24	25.24	25.17	25.14
Reserves and Surplus	2,183.19	1,934.42	1,528.54	1,228.78	1,026.45
Total Reserves and Surplus	2,183.19	1,934.42	1,528.54	1,228.78	1,026.45
Total Shareholders Funds	2,208.43	1,959.66	1,553.78	1,253.95	1,051.59
Minority Interest	0.00	0.00	0.00	0.00	-0.66
NON-CURRENT LIABILITIES
Long Term Borrowings	503.21	294.00	366.21	330.18	194.62
Deferred Tax Liabilities [Net]	174.31	147.11	130.39	93.15	80.73
Other Long Term Liabilities	4.02	1.30	0.71	1.10	1.66
Long Term Provisions	18.03	14.93	12.21	8.72	5.34
Total Non-Current Liabilities	699.57	457.34	509.52	433.15	282.35
CURRENT LIABILITIES
Short Term Borrowings	325.35	143.94	157.14	201.36	263.35
Trade Payables	306.59	341.30	268.37	236.92	178.55
Other Current Liabilities	236.44	252.41	166.00	172.93	99.97
Short Term Provisions	35.98	55.64	42.14	28.96	36.66
Total Current Liabilities	904.36	793.29	633.65	640.17	578.53
Total Capital And Liabilities	3,812.36	3,210.29	2,696.95	2,327.33	1,911.81
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,719.42	1,297.96	1,057.98	916.19	696.05
Intangible Assets	46.57	21.19	22.66	4.30	3.17
Capital Work-In-Progress	236.29	148.63	120.99	88.45	88.16
Fixed Assets	2,033.21	1,484.05	1,209.81	1,015.00	793.97
Non-Current Investments	16.19	9.00	8.87	33.93	40.68
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	104.36	71.32	47.77	37.56	37.61
Other Non-Current Assets	10.18	9.15	9.63	7.20	2.75
Total Non-Current Assets	2,198.38	1,607.96	1,299.67	1,117.28	875.01
CURRENT ASSETS
Current Investments	0.00	0.15	0.15	0.15	0.15
Inventories	926.56	847.58	741.03	669.89	466.40
Trade Receivables	353.00	449.52	417.82	349.08	367.21
Cash And Cash Equivalents	124.79	76.28	58.24	12.16	10.36
Short Term Loans And Advances	47.46	67.27	41.57	35.01	62.67
OtherCurrentAssets	162.17	161.53	138.47	143.76	130.01
Total Current Assets	1,613.98	1,602.33	1,397.28	1,210.05	1,036.80
Total Assets	3,812.36	3,210.29	2,696.95	2,327.33	1,911.81
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	412.66	543.71	220.90	207.68	287.79
BONUS DETAILS
Bonus Equity Share Capital	20.90	20.90	20.90	20.90	20.90
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	4.51	13.32	8.87	32.30	31.40
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00